Is Rocket Lab (RKLB) The Best Space Stock to Buy Now?
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish, with the key risk being the execution and timing of RKLB's Neutron rocket, which could lead to dilution and valuation compression if slips or underperforms. The key opportunity lies in RKLB's pivot to a vertically integrated satellite component supplier, with the Space Systems segment potentially providing a valuation floor if it scales as expected.
Risk: Neutron execution and timing
Opportunity: Space Systems segment growth
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
We just covered Avoid SpaceX and Buy These 11 Stocks Instead. Rocket Lab (NASDAQ:RKLB) ranks #10 (see Avoid SpaceX and Buy These 5 Stocks Instead).
Number of Hedge Fund Investors: 43
<pre><code> *Number of Hedge Fund Investors: 43* </code></pre>Before SpaceX IPO'd, Rocket Lab (NASDAQ:RKLB) was one of the top space infrastructure plays. But when SpaceX went public at a $2 trillion valuation, investors said, "Why buy the proxy when I can own the real thing? The stock is down about 30% over the past month. But Redditors believe the business fundamentals didn't get worse. The company still has all its contracts, all its backlog, and all its growth prospects. The selloff was pure capital reallocation, not deteriorating business performance.
Rocket Lab (NASDAQ:RKLB) operates multiple rocket systems. Their main workhorse is the Electron rocket, which launches small payloads into orbit. Clients include government agencies, defense contractors, and commercial satellite operators who need to get their satellites into space.
Neutron is Rocket Lab's (NASDAQ:RKLB) next-generation mega rocket, which is under development. Management expects Neutron to launch sometime in 2027. But here's why investors care: each Neutron launch is expected to generate $50 to $55 million in revenue. That's massive compared to what Electron brings in. If Rocket Lab can launch Neutron 20 times per year, that's $1.0 to $1.1 billion annually, just from Neutron. That's almost double their entire 2025 revenue projection of $602 million.
Polen 5Perspectives Small Mid Growth Strategy stated the following regarding Rocket Lab Corporation (NASDAQ:RKLB) in its fourth quarter 2025 investor letter:
"Rocket Lab Corporation (NASDAQ:RKLB) is an end-to-end space company which engages in the development of rocket launch and control systems for the space and defense industries. The company operates in two primary segments: Launch Services and Space Systems. Launch Services provides rides into orbit for small satellites with their Electron rocket. Space Systems designs and manufactures spacecraft components, satellite buses, and offers mission operations and other space solutions. The stock was up nearly 50% in the quarter on a strong set of earnings results and a growing backlog. While we initiated ...(
Click Here to Read the Letter in Detail)."
While we acknowledge the potential of RKLB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy**. **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Neutron's 2027 debut and $50-55M per-launch economics remain highly speculative and execution-dependent."
The article pitches RKLB as a SpaceX proxy with Neutron potentially delivering $1B+ annual revenue by the early 2030s, yet glosses over the 2027 first-flight target, historical small-launch delays, and the fact SpaceX remains private. Hedge-fund ownership at 43 names and a $602M 2025 revenue target sound promising, but Electron margins and Neutron capex burn are unproven at scale. The 30% drop may reflect rotation, yet also valuation compression if Neutron slips. The piece itself pivots to AI names, signaling limited conviction in RKLB's risk-reward.
Neutron could slip two-plus years while cash burn accelerates, leaving RKLB reliant on Electron's low-margin launches and dilutive financing before meaningful Neutron revenue arrives.
"The market is correctly shifting its focus from RKLB's current backlog to the high-stakes execution risk and potential capital dilution inherent in the Neutron development timeline."
The article’s premise that RKLB’s 30% drawdown is purely 'capital reallocation' due to SpaceX’s valuation is dangerously reductive. While RKLB has a solid moat in the small-launch segment and a growing Space Systems margin profile, the market is likely repricing the execution risk of the Neutron rocket. Developing a medium-lift launch vehicle is capital-intensive and historically plagued by delays. With RKLB burning cash to fund Neutron, the 2027 timeline is a massive 'show me' story. Investors are not just rotating; they are discounting the probability that Neutron’s development costs will necessitate dilutive equity raises before the vehicle achieves positive cash flow.
If RKLB successfully captures even a fraction of the launch market currently dominated by SpaceX’s Falcon 9, the current valuation provides an asymmetric entry point for a rare, vertically integrated space incumbent.
"RKLB's bull case hinges entirely on Neutron execution in 2027—a binary bet disguised as a backlog story, with no margin of safety if launch cadence or pricing disappoints."
The article conflates two separate things: a 30% selloff (real) and deteriorating fundamentals (claimed absent). But that's backwards. RKLB's Neutron—the $1B+ revenue thesis—won't launch until 2027, and that's management guidance, not contracted revenue. Current 2025 revenue is $602M; Electron margins are thin in competitive small-launch. The 43 hedge funds holding RKLB suggests institutional conviction, but hedge funds also rotate aggressively. The real question: does RKLB's backlog justify current valuation if Neutron slips (common in aerospace) or underperforms? The article assumes 20 launches/year at $50–55M each—that's 2x current Electron cadence with a completely new vehicle. That's not a risk-free extrapolation.
If Neutron launches on schedule in 2027 and achieves even 10 launches/year at $50M, RKLB's revenue compounds 25%+ annually through 2030, justifying a re-rating that makes today's price look cheap in hindsight.
"Neutron revenue is contingent on execution and a sustained 20-launch-per-year cadence by 2027, making it a high-risk near-term catalyst rather than a guaranteed driver."
Article leans into Neutron as the revenue game-changer, but the core counterpoint is timing and execution risk. Neutron is still under development (2027 launch target) and the $50-55 million per launch cadence assumes a healthy demand, flawless cadence, and no delays or cost overruns. Even with a growing Electron backlog, RKLB remains exposure-heavy to defense and government budgets, which are cyclical and prone to delays. The bear case compounds if gross margins shrink as capex rises, or if SpaceX and other players steal share with cheaper access to orbit. Valuation would require not only Neutron success but also durable Electron throughput and margin expansion.
If Neutron proves ahead of schedule and captures a broad mix of commercial and defense launches, RKLB could re-rate meaningfully, making a pure neutral stance miss a big upside.
"Defense budget timing plus thin Electron margins turn any Neutron delay into forced dilution far sooner than launch cadence alone implies."
Claude rightly questions the 20 launches/year Neutron cadence as unrealistic extrapolation, yet the deeper unaddressed link is how Electron's thin margins already signal that any 2027 slip forces immediate reliance on defense budgets prone to congressional delays. Hedge-fund holdings at 43 names then become exit liquidity rather than conviction, accelerating dilution before positive cash flow.
"The high-margin Space Systems segment provides a valuation floor that mitigates the binary risk of Neutron's launch timeline."
Grok and Claude focus on the launch cadence, but you are all ignoring the Space Systems segment. RKLB is pivoting from a pure-play launcher to a vertically integrated satellite component supplier. This high-margin business, not just Neutron, is what will bridge the cash flow gap. If Space Systems continues to grow at 30%+ CAGR, it provides a valuation floor that makes the 'dilution or bust' narrative for Neutron far less binary than the panel suggests.
"Space Systems could be RKLB's cash-flow savior, but only if its margin profile and growth rate materially outpace Neutron's capex burn through 2027—that gap is unquantified and material."
Gemini's Space Systems pivot is the first genuinely new angle, but it's also the most testable claim on the panel. If Space Systems is truly 30%+ CAGR and high-margin, why hasn't the article or any panelist quantified its 2025-2027 contribution to cash flow? Without specific revenue/margin guidance for that segment, invoking it as a 'valuation floor' is speculative. The bridge narrative only works if Space Systems scales faster than Neutron capex accelerates—that's the real bet, not just existence.
"Space Systems' valuation floor is speculative and doesn't guarantee RKLB's upside if Neutron delays or underperforms."
Gemini's Space Systems pivot as a valuation floor assumes a steady, high-margin ramp that isn't quantified for 2025-2027. Even if Space Systems scales, RKLB still faces Neutron capex burn and potential dilution before meaningful Neutron revenue arrives. The real risk isn't just growth; it's whether Space Systems delivers sufficient cash flow fast enough to support the current multiple if Neutron slips. That floor remains speculative, not guaranteed.
The panel consensus is bearish, with the key risk being the execution and timing of RKLB's Neutron rocket, which could lead to dilution and valuation compression if slips or underperforms. The key opportunity lies in RKLB's pivot to a vertically integrated satellite component supplier, with the Space Systems segment potentially providing a valuation floor if it scales as expected.
Space Systems segment growth
Neutron execution and timing